Mitsubishi Tanabe Pharma Corporation

Mitsubishi Tanabe Pharma Corporation (Japan) holds 0 active US FDA Type II Drug Master Files and 11 inactive and has DMF or CEP filings on record for 7 active ingredients. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Mitsubishi Tanabe Pharma Corporation: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/mitsubishi-tanabe-pharma-corporation

Overview

Mitsubishi Tanabe Pharma Corporation is a pharmaceutical company based in Japan. It is engaged in the research, development, manufacture, and sale of pharmaceutical products, focusing on novel and unique pharmaceuticals for specialized fields like cardiovascular and central nervous system diseases.

Core services & business areas

Drug DiscoveryDrug DevelopmentRegulatory AffairsMarketingSales

Therapeutic areas

Active ingredients with DMF or CEP filings

Substances for which Mitsubishi Tanabe Pharma Corporation holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

Mitsubishi Tanabe Pharma Corporation holds 0 active (11 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • MT-7716 DRUG SUBSTANCEInactive2009-12-21
  • MP-124 DRUG SUBSTANCEInactive2006-06-28
  • Y-39983 DRUG SUBSTANCEInactive2006-05-22
  • MP-513 DRUG SUBSTANCEInactive2005-09-09
  • MCC-257Inactive2002-07-30
  • MCI-196 DRUG SUBSTANCEInactive2002-04-22
  • MKC-242 BULK DRUG SUBSTANCEInactive1999-06-29
  • MCC-555Inactive1999-02-17
  • MCC-135 (BULK DRUG SUBSTANCE)Inactive1998-07-15
  • DILTIAZEM HYDROCHLORIDE (PROCESS C)Inactive1993-07-09
  • MCI-9038 ARGATROBAN DRUG SUB.Inactive1988-12-08

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to Mitsubishi Tanabe Pharma Corporation in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this Mitsubishi Tanabe Pharma Corporation?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.